Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18

Results from the ATHENA HPV study

J. Thomas Cox, Philip E. Castle, Catherine M. Behrens, Abha Sharma, Thomas C. Wright, Jack Cuzick

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Objective: The objective of the study was to compare 9 cervical cancer screening strategies to the current screening standard (cytology with human papillomavirus [HPV] triage of atypical squamous cells of undetermined significance) for the detection of high-grade cervical disease. Study Design: Women (n = 34,254) aged 30 years or older from the Addressing the Need for Advanced HPV Diagnostics (ATHENA) study underwent screening with cytology and HPV testing with simultaneous HPV16/18 genotyping; those with atypical squamous cells of undetermined significance cytology or greater or HPV-positive status were referred for colposcopy. Results: In general, screening strategies that offered greater sensitivity also required more referral to colposcopy. HPV testing was more sensitive than cytology for detection of cervical intraepithelial neoplasia grade 2 or greater, but strategies that depended on cytology for triage of HPV-positive women decreased this sensitivity. Various strategies of cotesting with cytology increased sensitivity but did so by increasing testing. Strategies that included integrated HPV16/18 testing provided more efficient referral to colposcopy. Conclusion: Strategies that maximize detection of women at greatest risk of cervical intraepithelial neoplasia grade 3 or greater by immediate referral to colposcopy, with follow-up testing of women at intermediate risk, maximize the benefits of cervical cancer screening while decreasing the potential harm. Incorporating screening with HPV and triage of HPV-positive women by a combination of genotyping for HPV16/18 and cytology provided a good balance between maximizing sensitivity (benefit) and specificity by limiting the number of colposcopies (potential harm).

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume208
Issue number3
DOIs
StatePublished - Mar 2013

Fingerprint

Human papillomavirus 18
Human papillomavirus 16
Early Detection of Cancer
Uterine Cervical Neoplasms
Cell Biology
Colposcopy
Triage
Cervical Intraepithelial Neoplasia
Referral and Consultation
Sensitivity and Specificity

Keywords

  • Addressing the Need for Advanced HPV Diagnostics
  • atypical squamous cells of undetermined significance
  • cotesting
  • human papillomavirus
  • human papillomavirus 16/18
  • low-grade squamous intraepithelial lesion

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18 : Results from the ATHENA HPV study. / Cox, J. Thomas; Castle, Philip E.; Behrens, Catherine M.; Sharma, Abha; Wright, Thomas C.; Cuzick, Jack.

In: American Journal of Obstetrics and Gynecology, Vol. 208, No. 3, 03.2013.

Research output: Contribution to journalArticle

@article{cc3ec85abe06453e9117e260f1799045,
title = "Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: Results from the ATHENA HPV study",
abstract = "Objective: The objective of the study was to compare 9 cervical cancer screening strategies to the current screening standard (cytology with human papillomavirus [HPV] triage of atypical squamous cells of undetermined significance) for the detection of high-grade cervical disease. Study Design: Women (n = 34,254) aged 30 years or older from the Addressing the Need for Advanced HPV Diagnostics (ATHENA) study underwent screening with cytology and HPV testing with simultaneous HPV16/18 genotyping; those with atypical squamous cells of undetermined significance cytology or greater or HPV-positive status were referred for colposcopy. Results: In general, screening strategies that offered greater sensitivity also required more referral to colposcopy. HPV testing was more sensitive than cytology for detection of cervical intraepithelial neoplasia grade 2 or greater, but strategies that depended on cytology for triage of HPV-positive women decreased this sensitivity. Various strategies of cotesting with cytology increased sensitivity but did so by increasing testing. Strategies that included integrated HPV16/18 testing provided more efficient referral to colposcopy. Conclusion: Strategies that maximize detection of women at greatest risk of cervical intraepithelial neoplasia grade 3 or greater by immediate referral to colposcopy, with follow-up testing of women at intermediate risk, maximize the benefits of cervical cancer screening while decreasing the potential harm. Incorporating screening with HPV and triage of HPV-positive women by a combination of genotyping for HPV16/18 and cytology provided a good balance between maximizing sensitivity (benefit) and specificity by limiting the number of colposcopies (potential harm).",
keywords = "Addressing the Need for Advanced HPV Diagnostics, atypical squamous cells of undetermined significance, cotesting, human papillomavirus, human papillomavirus 16/18, low-grade squamous intraepithelial lesion",
author = "Cox, {J. Thomas} and Castle, {Philip E.} and Behrens, {Catherine M.} and Abha Sharma and Wright, {Thomas C.} and Jack Cuzick",
year = "2013",
month = "3",
doi = "10.1016/j.ajog.2012.11.020",
language = "English (US)",
volume = "208",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18

T2 - Results from the ATHENA HPV study

AU - Cox, J. Thomas

AU - Castle, Philip E.

AU - Behrens, Catherine M.

AU - Sharma, Abha

AU - Wright, Thomas C.

AU - Cuzick, Jack

PY - 2013/3

Y1 - 2013/3

N2 - Objective: The objective of the study was to compare 9 cervical cancer screening strategies to the current screening standard (cytology with human papillomavirus [HPV] triage of atypical squamous cells of undetermined significance) for the detection of high-grade cervical disease. Study Design: Women (n = 34,254) aged 30 years or older from the Addressing the Need for Advanced HPV Diagnostics (ATHENA) study underwent screening with cytology and HPV testing with simultaneous HPV16/18 genotyping; those with atypical squamous cells of undetermined significance cytology or greater or HPV-positive status were referred for colposcopy. Results: In general, screening strategies that offered greater sensitivity also required more referral to colposcopy. HPV testing was more sensitive than cytology for detection of cervical intraepithelial neoplasia grade 2 or greater, but strategies that depended on cytology for triage of HPV-positive women decreased this sensitivity. Various strategies of cotesting with cytology increased sensitivity but did so by increasing testing. Strategies that included integrated HPV16/18 testing provided more efficient referral to colposcopy. Conclusion: Strategies that maximize detection of women at greatest risk of cervical intraepithelial neoplasia grade 3 or greater by immediate referral to colposcopy, with follow-up testing of women at intermediate risk, maximize the benefits of cervical cancer screening while decreasing the potential harm. Incorporating screening with HPV and triage of HPV-positive women by a combination of genotyping for HPV16/18 and cytology provided a good balance between maximizing sensitivity (benefit) and specificity by limiting the number of colposcopies (potential harm).

AB - Objective: The objective of the study was to compare 9 cervical cancer screening strategies to the current screening standard (cytology with human papillomavirus [HPV] triage of atypical squamous cells of undetermined significance) for the detection of high-grade cervical disease. Study Design: Women (n = 34,254) aged 30 years or older from the Addressing the Need for Advanced HPV Diagnostics (ATHENA) study underwent screening with cytology and HPV testing with simultaneous HPV16/18 genotyping; those with atypical squamous cells of undetermined significance cytology or greater or HPV-positive status were referred for colposcopy. Results: In general, screening strategies that offered greater sensitivity also required more referral to colposcopy. HPV testing was more sensitive than cytology for detection of cervical intraepithelial neoplasia grade 2 or greater, but strategies that depended on cytology for triage of HPV-positive women decreased this sensitivity. Various strategies of cotesting with cytology increased sensitivity but did so by increasing testing. Strategies that included integrated HPV16/18 testing provided more efficient referral to colposcopy. Conclusion: Strategies that maximize detection of women at greatest risk of cervical intraepithelial neoplasia grade 3 or greater by immediate referral to colposcopy, with follow-up testing of women at intermediate risk, maximize the benefits of cervical cancer screening while decreasing the potential harm. Incorporating screening with HPV and triage of HPV-positive women by a combination of genotyping for HPV16/18 and cytology provided a good balance between maximizing sensitivity (benefit) and specificity by limiting the number of colposcopies (potential harm).

KW - Addressing the Need for Advanced HPV Diagnostics

KW - atypical squamous cells of undetermined significance

KW - cotesting

KW - human papillomavirus

KW - human papillomavirus 16/18

KW - low-grade squamous intraepithelial lesion

UR - http://www.scopus.com/inward/record.url?scp=84874768149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874768149&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2012.11.020

DO - 10.1016/j.ajog.2012.11.020

M3 - Article

VL - 208

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3

ER -